Found 26 matching trials
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED) PHASE3 This is a 105-week clinical study in patients with heterozygous familial hy...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) PHASE3 This is a 12-Week clinical trial in patients with Primary hypercholesterole...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118) PHASE3 This study is being done to find out if tablets containing extended release...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of MK0524A on Cholesterol Levels (0524A-048) PHASE3 The primary objective of the study is to assess the effects of MK0524A in r...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) PHASE3 This is a 12-week clinical trial in lipid clinic patients for whom niacin t...
Show More Location
Multiple Locations
Learn More & Join Trial
Endpoint Validation Study (0524A-015) PHASE2 To determine the most effective daily dose of MK0524A when compared with pl...
Show More Location
Multiple Locations
Learn More & Join Trial
Lipid Efficacy Study (0524B-022)(COMPLETED) PHASE3 This is a 12-week clinical trial in patients with primary hypercholesterole...
Show More Location
Multiple Locations
Learn More & Join Trial
Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119) N/A This survey is being conducted to assess the safety and efficacy of niacin ...
Show More Location
Multiple Locations
Learn More & Join Trial
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) PHASE3 This is a 12-week clinical trial in participants with mixed hyperlipidemia ...
Show More Location
Multiple Locations
Learn More & Join Trial
An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) PHASE2 This is a 3-week trial in normal healthy or lipid clinic patients studying ...
Show More Location
Multiple Locations
Learn More & Join Trial